MoneyWorks4Me

Morepen Laboratories - Quaterly Results

11 Nov 2024 Evaluate
With no major difference for the quarter endedSeptember 2024 , the total revenue stood at Rs. 3837.00  millions.The Profit  for the quarter ended September 2024 of  Rs. 319.28  millions  grew by 60.25% from Rs. 199.24 millions.OP of the company witnessed a marginal growth to 476.96 millions from 325.99 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3837.00 3812.58 0.64 7693.43 7503.61 2.53 15375.94 13388.83 14.84
Other Income 46.31 28.38 63.18 77.03 49.22 56.50 125.66 57.59 118.20
PBIDT 476.96 325.99 46.31 993.78 594.86 67.06 1743.84 830.29 110.03
Interest 10.50 4.55 130.77 20.94 7.38 183.74 35.09 19.81 77.13
PBDT 466.46 321.44 45.12 972.84 587.48 65.60 1708.75 810.48 110.83
Depreciation 37.90 48.10 -21.21 73.80 97.03 -23.94 219.00 180.06 21.63
PBT 428.56 273.34 56.79 899.04 490.45 83.31 1489.75 630.42 136.31
TAX 109.28 74.10 47.48 229.26 132.72 72.74 380.40 167.99 126.44
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.36 2.03 -314.78
PAT 319.28 199.24 60.25 669.78 357.73 87.23 1109.35 462.43 139.90
Equity 1095.84 1022.27 7.20 1095.84 1022.27 7.20 1022.27 1022.27 0.00
PBIDTM(%) 12.43 8.55 45.38 12.92 7.93 62.94 11.34 6.20 82.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..